# Clinical Study Comparing Two Models of a Travoprost Intraocular Implant

> **NCT03868124** · PHASE3 · COMPLETED · sponsor: **Glaukos Corporation** · enrollment: 560 (actual)

## Conditions studied

- Glaucoma, Open-Angle
- Ocular Hypertension

## Interventions

- **COMBINATION_PRODUCT:** G2-TR intraocular implant containing travoprost
- **DRUG:** Sham surgery + active-comparator eye drops

## Key facts

- **NCT ID:** NCT03868124
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-17
- **Primary completion:** 2022-06-10
- **Final completion:** 2024-06-19
- **Target enrollment:** 560 (ACTUAL)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03868124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03868124, "Clinical Study Comparing Two Models of a Travoprost Intraocular Implant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03868124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*